Single Cell Multiomics Market by Type,, Application, Technique, and End User, : Global Opportunity Analysis and Industry Forecast, 2021–2030

Single Cell Multiomics Market by Type,, Application, Technique, and End User, : Global Opportunity Analysis and Industry Forecast, 2021–2030

  • June 2021 •
  • 287 pages •
  • Report ID: 6126672 •
  • Format: PDF
Single Cell Multiomics Market by Type, (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, and Single Cell Metabolomics), Application (Oncology, Cell Biology, Neurology, and Others), Technique (Single-Cell Isolation & Dispensing and Single-Cell Analysis), and End User, (Academic Institutes, Contract Research Organizations, and Pharmaceutical & Biotech Companies): Global Opportunity Analysis and Industry Forecast, 2021–2030

The global single cell multiomics market was valued at $2,458.80 million in 2020 and is projected to reach $13,908.30 million by 2030, registering a CAGR of 19.0% from 2021 to 2030.
Single cell multiomics technologies typically measure numerous types of molecules from the same individual cell, allowing more profound biological insight than can be inferred by analyzing each molecular layer from separate cells. Furthermore, single cell multiomics technologies can reveal cellular heterogeneity at multiple molecular layers within a population of cells and reveal how this variation is coupled or uncoupled between the captured omic layers. Furthermore, advances in single-cell isolation and barcoding technologies offer unprecedented opportunities to profile DNA, mRNA, and proteins at a single-cell resolution. Recently, bulk multiomics analyses, such as multidimensional genomic and proteogenomic analyses, have proven beneficial for obtaining a comprehensive understanding of cellular events. Moreover, this benefit has facilitated the development of single-cell multiomics analysis, which allows cell type specific gene regulation to be examined.
The factors that drive the single cell multiomics market growth include technological advancements in single-cell analysis products and rise in number of large-scale genomics studies leveraging single-cell RNA Sequencing (sc-RNA). Moreover, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders and rising disposable income in emerging economies drive the growth of the single cell multiomics market. However, high cost of single-cell analysis, dearth of skilled professionals, and integration of data & limited availability of large online data storage and analysis platforms are expected to restrain the growth of the market. Moreover, increasing funding in research of single cell multiomics is anticipated to provide lucrative growth opportunities for market players.
The global single cell multiomics market is segmented on the basis of type, application, technique, end user, and region. On the basis of type, the market is categorized into single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. By application, it is classified into oncology, cell biology, neurology, and others. By technique, it is divided into single-cell isolation & dispensing and single-cell analysis. Furthermore, single-cell isolation is further classified into oncology, cell biology, neurology, and others. Moreover, single-cell analysis is further divided into oncology, cell biology, neurology, and others. By end user, it is segmented into academic institutes, contract research organizations, and pharmaceutical & biotech companies. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global single cell multiomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps understand the applications and products of single cell multiomics used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS
• By Type
o Single Cell Genomics
o Single Cell Proteomics
o Single Cell Transcriptomics
o Single Cell Metabolomics
• By Application
o Oncology
o Cell Biology
o Neurology
o Others
• By Technique
o Single-Cell Isolation & Dispensing
o Oncology
o Cell Biology
o Neurology
o Others
o Single-Cell Analysis
o Oncology
o Cell Biology
o Neurology
o Others
• By End User
o Academic Institutes
o Contract Research Organizations
o Pharmaceutical & Biotech Companies

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
? Bio-Rad Laboratories (Celsee, Inc.)
? BGI Genomics Co. Ltd.
? Cytiva life science (Previously GE)
? Fluidigm Corporation
? Illumina, Inc.
? 10x Genomics
? NanoString Technologies
? MissionBio
? QIAGEN N.V.
? Takara Bio